Director, Facilities - Contract Role

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Conshohocken, PA | 09/12/2025 23:12:09 PM | Salario: S/. No Especificado | Empresa: Madrigal

Director, Commercial Assessments

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra.... Madrigal will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established...

Lugar: Conshohocken, PA | 09/12/2025 19:12:50 PM | Salario: S/. No Especificado | Empresa: Madrigal

Senior Manager, AI and Data Science

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial...

Lugar: Conshohocken, PA | 09/12/2025 18:12:32 PM | Salario: S/. $163000 - 200000 per year | Empresa: Madrigal

Senior Director, Commercial Patient Hub Data Operations

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Conshohocken, PA | 07/12/2025 01:12:09 AM | Salario: S/. No Especificado | Empresa: Madrigal

Director, Data Architecture Development

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Waltham, MA | 06/12/2025 23:12:12 PM | Salario: S/. No Especificado | Empresa: Madrigal

Director, Platform and Solutions

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Waltham, MA | 05/12/2025 03:12:39 AM | Salario: S/. No Especificado | Empresa: Madrigal

Associate Director, Patient Support Solutions

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Waltham, MA | 04/12/2025 22:12:09 PM | Salario: S/. $172000 - 210000 per year | Empresa: Madrigal

Executive Director, Global Market Planning and Operations

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2...

Lugar: Conshohocken, PA | 04/12/2025 19:12:34 PM | Salario: S/. No Especificado | Empresa: Madrigal

Director, Global Health Economics & Outcomes Research

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established. Applications are being...

Lugar: Conshohocken, PA | 04/12/2025 03:12:28 AM | Salario: S/. No Especificado | Empresa: Madrigal

Senior Director, Global Scientific Content

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Conshohocken, PA | 03/12/2025 01:12:29 AM | Salario: S/. No Especificado | Empresa: Madrigal
«Anterior12345